These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31306860)

  • 21. Severe hypothermia in a neonate following antenatal exposure to haloperidol.
    Mohan MS; Patole SK; Whitehall JS
    J Paediatr Child Health; 2000 Aug; 36(4):412-3. PubMed ID: 10940186
    [No Abstract]   [Full Text] [Related]  

  • 22. The emergency treatment of depression complicated by psychosis or agitation.
    Glick RL; Ghaemi SN
    J Clin Psychiatry; 2000; 61 Suppl 14():43-8. PubMed ID: 11154016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug reactions experienced by out-patients taking chlorpromazine or haloperidol at Zomba Mental Hospital, Malawi.
    Chikowe I; Domingo M; Mwakaswaya V; Parveen S; Mafuta C; Kampira E
    BMC Res Notes; 2019 Jul; 12(1):376. PubMed ID: 31262359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
    Reus VI; Fochtmann LJ; Eyler AE; Hilty DM; Horvitz-Lennon M; Jibson MD; Lopez OL; Mahoney J; Pasic J; Tan ZS; Wills CD; Rhoads R; Yager J
    Am J Psychiatry; 2016 May; 173(5):543-6. PubMed ID: 27133416
    [No Abstract]   [Full Text] [Related]  

  • 25. Atypical antipsychotic medications in the psychiatric emergency service.
    Currier GW
    J Clin Psychiatry; 2000; 61 Suppl 14():21-6. PubMed ID: 11154013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
    Tariot PN; Schneider L; Katz IR; Mintzer JE; Street J; Copenhaver M; Williams-Hughes C
    Am J Geriatr Psychiatry; 2006 Sep; 14(9):767-76. PubMed ID: 16905684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group.
    Brook S; Lucey JV; Gunn KP
    J Clin Psychiatry; 2000 Dec; 61(12):933-41. PubMed ID: 11206599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Best clinical practice with ziprasidone IM: update after 2 years of experience.
    Zimbroff DL; Allen MH; Battaglia J; Citrome L; Fishkind A; Francis A; Herr DL; Hughes D; Martel M; Preval H; Ross R
    CNS Spectr; 2005 Sep; 10(9):1-15. PubMed ID: 16247923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of haloperidol in the agitated, critically ill pediatric patient with burns.
    Brown RL; Henke A; Greenhalgh DG; Warden GD
    J Burn Care Rehabil; 1996; 17(1):34-8. PubMed ID: 8808357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.
    Chouinard G; Annable L; Turnier L; Holobow N; Szkrumelak N
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S114-21. PubMed ID: 8306241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia.
    Zhang H; Wang G; Zhao J; Xie S; Xu X; Shi J; Deng H; Li K; Gao C; Wang X; Vanderburg D; Pan S; Tang H; Shu L; Karayal ON
    J Clin Psychopharmacol; 2013 Apr; 33(2):178-85. PubMed ID: 23422376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Outcomes in Patients Taking Inhaled Loxapine, Haloperidol, or Ziprasidone in the Emergency Department.
    McDowell M; Nitti K; Kulstad E; Cirone M; Shah R; Rochford D; Walsh R; Hesse K
    Clin Neuropharmacol; 2019; 42(2):23-26. PubMed ID: 30747748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
    Fruensgaard K; Korsgaard S; Jorgensen H; Jensen K
    Acta Psychiatr Scand; 1977 Oct; 56(4):256-64. PubMed ID: 335787
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
    Baldaçara L; Sanches M; Cordeiro DC; Jackoswski AP
    Braz J Psychiatry; 2011 Mar; 33(1):30-9. PubMed ID: 21537720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.
    Weintraub D; Katz IR
    Psychiatr Clin North Am; 2005 Dec; 28(4):941-83, ix-x. PubMed ID: 16325736
    [No Abstract]   [Full Text] [Related]  

  • 36. What about temperature? Haloperidol-induced hypotermia.
    Signorelli MS; Nalis F; Battiato M; Aguglia E
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24051146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
    Raskind MA; Wang LY
    Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502
    [No Abstract]   [Full Text] [Related]  

  • 39. High-dose treatment with haloperidol: the effect of dose reduction.
    Volavka J; Cooper TB; Czobor P; Lindenmayer JP; Citrome LL; Mohr P; Bark N
    J Clin Psychopharmacol; 2000 Apr; 20(2):252-6. PubMed ID: 10770466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.